Thymosin Alpha-1 vs Thymalin — Peptide Comparison

Thymosin Alpha-1 vs Thymalin — Peptide Comparison Thymosin Alpha-1 vs Thymalin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymosin Alpha-1 1.6–3.2 mg Thymalin 5–10 mg Frequency Twice weekly Once daily Administration Subcutaneous injection Intramuscular injection Cycle Length 8-12 weeks 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Limited human trials Efficacy Immune Activation Infection Fighting Immune Balance Immune Restoration Longevity Support Disease Prevention Technical Data Molecular Formula C129H215N33O55 Molecular Weight 3108.32 g/mol Half-Life Approximately 2 hours Bioavailability High when injected subcutaneously (rapid absorption, peak at ~2 hours) CAS Number 62304-98-7 Complex mixture; active dipeptide EW: C16H19N3O5 Polypeptide complex; components 250-1000 Da; active dipeptide EW ~321 Da Not precisely characterized for complex; immune effects persist weeks post-administration High via intramuscular or subcutaneous injection 63958-90-7 Protocols standard 1.6 mg Twice weekly (3-4 days apart) 6-12 months Established clinical dose for thymalfasin (Zadaxin); body-surface-scaled as 900 mcg/m2 [4][6]. Phase III chronic hepatitis B trials used 1.6 mg SC twice weekly for 6-12 months [4]. advanced 1.6 mg daily, then 1.6 mg twice weekly Daily for an initial loading period, then twice weekly 12+ weeks Some immune-adjuvant and acute protocols front-load with daily dosing before settling to the standard twice-weekly schedule [4][6]. 5-10 mg reconstituted in saline 5-10 day course, often repeated every 6 months Reflects the Russian clinical course used in immune-restoration and gerontology protocols, typically 10 mg IM daily for 5-10 days [1]. 10 mg Up to 20 day course, repeated every 6 months Subcutaneous administration is used in community practice at the same 10 mg daily dosing; longer 20-day courses are described for cyclical immune support [1]. Applications Chronic Hepatitis B or C Support Thymosin Alpha-1 has its strongest clinical evidence here. Multiple trials show it helps clear viral loads and normalize liver enzymes, especially when combined with antiviral medications. It's approved in over 30 countries specifically for hepatitis treatment. Cancer Treatment Support When used alongside chemotherapy, Thymosin Alpha-1 may help maintain immune function that chemo tends to suppress. Research in lung cancer, melanoma, and liver cancer shows improved outcomes when added to standard treatments. It helps your immune system keep fighting even during tough treatments. Age-Related Immune Decline As you age, your thymus shrinks and produces less thymosin naturally—a process called immunosenescence. Supplementing with Thymosin Alpha-1 may help compensate, keeping your immune defenses more youthful and responsive. Think of it as replacing what your body makes less of over time. Severe Infection Recovery In sepsis and critical infections, Thymosin Alpha-1 has shown promise for reducing mortality by helping restore immune balance. It's particularly interesting because it modulates immunity rather than just boosting it—calming overreaction while enhancing pathogen-fighting ability. Aging Adults Seeking Immune Support Thymalin is especially valuable for people over 55 whose thymus gland has naturally shrunk with age. By stimulating thymic function, it helps restore the immune training center that your body relies on to fight infections and stay healthy. Longevity and Anti-Aging Protocols Clinical studies tracking patients for 6-8 years showed Thymalin reduced mortality by 2.0-2.1-fold. Combined with Epitalon, the mortality reduction reached an impressive 4.1-fold, making this combination one of the most studied longevity peptide protocols. Seasonal Illness Prevention Research shows Thymalin cuts respiratory infection rates by 2.0-2.4-fold. A short 10-day course before cold and flu season can significantly boost your immune defenses for months afterward. Safety Profile Common Injection site reactions Mild fatigue Flu-like symptoms Uncommon Mild fever Lymph node awareness Serious Allergic reaction No side effects in most patients Mild injection site reaction Transient low-grade fever Mild flu-like symptoms Temporary headache Severe allergic reaction Research Status FDA Status FDA approved for other use Safety Overview Thymosin Alpha-1 has one of the most extensive safety records of any peptide, with decades of clinical use across multiple countries. Studies consistently report minimal side effects—mostly limited to mild injection site reactions. The 2-hour half-life means it doesn't accumulate in your system. It's been used safely in thousands of patients with hepatitis, cancer, and other serious conditions. Contraindications xOrgan transplant recipients on immunosuppressants xActive autoimmune disease flares xKnown allergy to thymosin peptides xPregnancy or breastfeeding xChildren under 18 without medical supervision Research compound Thymalin has an excellent safety profile based on over 40 years of clinical use in Russia. Most patients experience zero side effects, and the peptide complex has been described as 'practically non-toxic' in research literature. It has been used safely in thousands of patients, including elderly populations over extended periods. xActive thymic tumors or malignancies xKnown hypersensitivity to animal-derived peptide products xPregnancy and breastfeeding (insufficient safety data) xSevere uncontrolled autoimmune disease without medical supervision Decision Guide Choose Thymosin Alpha-1 if... Immune system strengthening Chronic infection support Cancer adjunct therapy Healthy aging immune support Choose Thymalin if... Immune system restoration in aging adults Longevity and healthy aging support Reducing infection frequency and severity Multi-system health optimization